Motus GI to go public with $25M IPO — 3 insights

Motus GI will sell 4.25 million shares of its common stock at $6 per share as it attempts to raise $25.5 million through a U.S.-based initial public offering, Seeking Alpha reports.

Advertisement

Here’s what you should know:

1. Motus GI developed the Pure-Vu System, which assists with colonoscopy preparation.

2. Motus does not yet have a reimbursement code for the Pure-Vu system, and thus needs the public offering to raises funds for further clinical trials.

3. Motus will trade under the symbol MOTS.

More articles on gastroenterology: 
Physicians Endoscopy, Exact Sciences & more — 6 GI company key notes
How Anthem’s new anesthesia policy for cataract surgery will affect ASCs — 5 insights
Dr. Brad Cohen replaces hip of celebrity chef Jeffrey Strauss — 4 insights

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.